Evidence that new biomimetic controlled-release capsules may help in gum disease
(Press-News.org) PHILADELPHIA, Aug. 20, 2012 — Scientists are trying to open a new front in the battle against gum disease, the leading cause of tooth loss in adults and sometimes termed the most serious oral health problem of the 21st century. They described another treatment approach for the condition in a report here today at the 244th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.
"Our technology uses controlled-release capsules filled with a protein that would be injected in the pockets between the gums and the teeth," said Steven Little, Ph.D., who reported on the research. "That's ground-zero for periodontal disease ― 'gum disease' ― the place where bacteria breed and inflammation occurs. The capsules dissolve over time, releasing a protein that acts as a homing beacon. It guides immune cells to the diseased area, reducing inflammation, creating an environment that fights the disease process and even could create conditions favorable for gum tissue to regrow."
Little and colleagues, who are with the University of Pittsburgh, have evidence from laboratory experiments with mice ― stand-ins for humans in early research of this kind that cannot be done with actual patients ― that the approach does foster healing and regrowth of gum tissue damaged by periodontal disease.
A bacterial infection causes periodontal disease. It first appears as mild tenderness and bleeding of the gums. It leads to inflammation and, if left untreated, can damage the gums so that they recede and lose their attachment to the teeth. It may progress even further and damage bone and other tissues that hold teeth firmly in place. Surprisingly, gum disease has a number of deleterious effects outside the mouth, with some studies linking inflammation in the gums to an increased risk of heart disease, stroke and preterm delivery in pregnant women.
Treatment includes scaling, root planing and other procedures to remove the plaque and bacteria that have accumulated in pockets between the teeth and gums. Dentists may combine this with antibiotics to fight the bacteria involved in gum disease.
Many scientists are seeking alternative treatments that kill the bacteria. Little's group is taking an entirely different approach. They are targeting the inflammation process. "Although bacteria start the disease, inflammation is what keeps it going and causes progressive damage," Little explained.
To reduce inflammation at the gums, Little and colleagues designed injectable controlled-release capsules containing a protein encased inside a plastic-like polymer material. The polymer is already used in medicine in dissolvable sutures. After the capsules are injected, the polymer slowly breaks down, releasing the protein encapsulated inside. The protein, termed a chemokine, is already produced by the body's existing cells in order to summon specialized white blood cells to a specific site. Scientists previously tried to keep those cells, termed lymphocytes, away from the gums so as to block inflammation from occurring in the first place.
"It seems counterintuitive to lure in a lymphocyte, which is traditionally thought of as an inflammatory cell, if there's inflammation," Little pointed out. "But remember that a certain level of natural inflammation is required to fight off an infection. Inflammation is inherently a good thing, but too much of it is a bad thing. That's why we aim to restore the immune balance, or homeostasis."
Little's team injected the capsules into mice and discovered evidence that disease symptoms are dramatically reduced and that proteins and other substances involved in regrowth of gum tissue had appeared. Little said that this finding offers encouragement that the treatment could not only rebalance the immune system, but also prompt regrowth of lost gum and bone tissue in the mouth.INFORMATION:
The researchers acknowledged funding from the Arnold and Mabel Beckman Foundation, the Wallace H. Coulter Foundation and the National Institute of Dental and Craniofacial Regeneration of the NIH (1R01DE021058-01).
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 164,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact email@example.com.
Note to journalists: Please report that this research was presented at a meeting of the American Chemical Society.
Periodontal disease is characterized by destructive inflammation of the gums and supporting ligament and is considered the most pressing oral health concern today. Current therapies focus on elimination of the invasive bacteria through clinical procedures known as scaling and root planing and also the use of local antibiotics. However, recent literature suggests that although the bacteria initiate periodontal disease, symptoms are perpetuated by an imbalanced immune response and can even be characterized by an absence of a subset of lymphocytes that can promote immunological hypo-responsiveness and tolerance. We hypothesized that recruiting this subset of lymphocytes back into the periodontium would decrease the symptoms of periodontal disease, and restore immunological homeostasis. In this talk, we will discuss how such targeted, lymphocyte-recruiting formulations appear to indeed abrogate periodontal disease symptoms in both murine and pre-clinical canine models and may even establish a pro-regenerative milieu.
ELSE PRESS RELEASES FROM THIS DATE:
PHILADELPHIA, Aug. 20, 2012 — A gallon of regular gasoline cost 31 cents, a first-class postage stamp 4 cents and an office visit to the doctor's office $5. John F. Kennedy was president. Lawrence of Arabia won the Academy Award for Best Picture. A new band called The Rolling Stones got lots of attention.
It was 1962, and today scientists are gathering here for a special symposium honoring the 50th anniversary of an agency that has improved the health and well-being of millions of people over the last half-century. The event, marking the golden anniversary of the National ...
PHILADELPHIA, Aug. 20, 2012 — Should Lady Justice, that centuries-old personification of truth and fairness in the legal system, cast off her ancient Roman robe, sword and scales and instead embrace 21st century symbols of justice meted out objectively without fear or favor? A scientist's laboratory jacket, perhaps? And a spiral strand of the genetic material DNA?
An unusual symposium that might beg such a question - showcasing chemistry's role in righting some of the highest-profile cases of innocent people proven guilty - unfolds today at the 244th National Meeting ...
PHILADELPHIA, Aug. 20, 2012 — With concerns about the possible health and environmental effects of oil dispersants in the Deepwater Horizon disaster still fresh in mind, scientists today described a new dispersant made from edible ingredients that both breaks up oil slicks and keeps oil from sticking to the feathers of birds.
"Each of the ingredients in our dispersant is used in common food products like peanut butter, chocolate and whipped cream," said Lisa K. Kemp, Ph.D. She reported on the dispersant at the 244th National Meeting & Exposition of the American Chemical ...
PHILADELPHIA, Aug. 20, 2012 — A new process for converting municipal waste, algae, corn stalks and similar material to gasoline, diesel and jet fuel is showing the same promise in larger plants as it did in laboratory-scale devices, the developers reported here today. It was part of the 244th National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society, which continues through Thursday.
"These results are essential in establishing the credibility of a process that may seem too good to be within the realm of possibility," ...
PHILADELPHIA, Aug. 20, 2012 — People in ancient Rome 2,000 years ago had better access to clean water and sanitation that keeps disease-causing human excrement out of contact with people than many residents of the 21st century, a scientist said here today.
Women in developing countries could play a major role in remedying the situation, if given the chance, she added. Jeanette A. Brown, Ph.D., spoke on the global crisis in availability of clean water and basic sanitation like toilets and sewage disposal at the 244th National Meeting & Exposition of the American Chemical ...
PHILADELPHIA, Aug. 20, 2012 — New scientific analysis strengthens the view that record-breaking summer heat, crop-withering drought and other extreme weather events in recent years do, indeed, result from human activity and global warming, Nobel Laureate Mario J. Molina, Ph.D., said here today.
Molina, who shared the 1995 Nobel Prize in Chemistry for helping save the world from the consequences of ozone depletion, presented the keynote address at the 244th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society. The meeting, ...
The number of new cases of heart failure in Ontario decreased 33% over a decade, suggesting preventive efforts may be working. However, mortality rates remain high for people with the disease, states a study published in CMAJ (Canadian Medical Association Journal).
Heart failure is a major cause of admission to hospital and has a high death rate for patients. In recent decades, the incidence has been increasing; in 2000, patients with heart failure accounted for the second highest number of days in hospital in Canada. However, there is some recent evidence that the number ...
Canada needs a national approach to managing its supply of pharmaceutical drugs, starting with a mandatory reporting system for drug shortages, argues an editorial in CMAJ (Canadian Medical Association Journal) and CPJ (Canadian Pharmacists Journal).
Shortages of drugs, particularly those used in chemotherapy, as well as antibiotics, antiepileptics and anesthetics, have become increasingly common, unpredictable and widespread in Canada. These shortages result in poorer health for Canadians, with consequences such as worsening of medical conditions, negative reactions ...
LA JOLLA, Calif., August 20, 2012 – The underlying causes of Alzheimer's disease are not fully understood, but a good deal of evidence points to the accumulation of β-amyloid, a protein that's toxic to nerve cells. β-amyloid is formed by the activity of several enzymes, including one called BACE1. Most Alzheimer's disease patients have elevated levels of BACE1, which in turn leads to more brain-damaging β-amyloid protein. In a paper published August 15 in The Journal of Neuroscience, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) ...
BLOOMINGTON, Ind. -- A groundbreaking new research study from Indiana University suggests there may be benefits to the controversial activities of "pro-ana" bloggers, the online community for people with eating disorders.
Most of the 33 bloggers from seven countries interviewed for the study, which has just been published in the journal Health Communication, said their writing activities provide a way to express themselves without judgment, which the authors believe can be crucial to their treatment.
"We don't know what are the effects of participating in this community ...
LAST 30 PRESS RELEASES: